Cell Therapy for Localized Scleroderma Can Reverse Fibrosis in Mice
A cell therapy based on injected genetically modified human skin cells and a pill that activates a protein has the capacity for breaking down fibrosis in localized scleroderma — at least in mice. Fibrocell and Intrexon will present preclinical data on their investigational cell therapy FCX-013 for the…